{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T06:07:38Z","timestamp":1784700458857,"version":"3.55.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Youth Scientific Research Fund Project of Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-Sen University","award":["YQ2025003"],"award-info":[{"award-number":["YQ2025003"]}]},{"name":"Clinical Research \u201cClimbing\u201d Program of the First Affiliated Hospital of Guangxi Medical University","award":["YYZS2020017"],"award-info":[{"award-number":["YYZS2020017"]}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dysregulation of lipid metabolism has been implicated in Parkinson\u2019s disease (PD), yet causal relationships remain unclear due to confounding factors inherent in observational studies. Most Mendelian randomization studies on lipid-PD relationships have been conducted in European populations, leaving the causal association in East Asian populations largely unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a bidirectional Mendelian randomization (MR) analysis using genome-wide association study (GWAS) data from the Integrative Epidemiology Unit (IEU) Open GWAS project for East Asian populations to assess the causal associations between four lipid traits \u2014 triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C)\u2014and PD. The primary MR analyses were conducted using the inverse-variance weighted (IVW) method. Sensitivity analyses included Cochran\u2019s Q test, MR-Egger regression, and leave-one-out analyses. We further conducted colocalization analysis to assess whether the four lipid traits and PD shared common genetic variants. Finally, we complemented the findings using a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Genetically predicted higher levels of TC (OR\u202f=\u202f0.476, 95% CI\u202f=\u202f0.269\u20130.843,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.011) and LDL-C (OR\u202f=\u202f0.494, 95% CI\u202f=\u202f0.289\u20130.845,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.010) were associated with a reduced risk of PD. No causal relationship was observed between TG or HDL-C and PD. Reverse MR analysis indicated no causal effect of PD on any of the lipid traits. Colocalization analysis did not support shared genetic variants between the lipid traits and PD (all PP.H4\u202f&amp;lt;\u202f0.8). In MPTP-induced PD mice, both TC and LDL-C levels were significantly lower than in controls.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides genetic evidence supporting a genetically predicted inverse association of TC and LDL-C with PD risk among East Asian populations. The underlying mechanisms and any therapeutic implications warrant further experimental investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2026.1841547","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:56:40Z","timestamp":1784699800000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum total cholesterol and low-density lipoprotein cholesterol are associated with Parkinson\u2019s disease in East Asian populations: a bidirectional Mendelian randomization study with complementary animal observation"],"prefix":"10.3389","volume":"18","author":[{"given":"Yanzi","family":"Bao","sequence":"first","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglin","family":"Li","sequence":"additional","affiliation":[{"name":"Wuming Hospital Affiliated To Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyue","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Neurology, Guangxi Hospital Division of the First Affiliated Hospital, Sun Yat-Sen University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousheng","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Guangxi Medical University","place":["Nanning, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1111\/j.1471-4159.2008.05254.x","article-title":"Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson\u2019s disease","volume":"105","author":"Bar-On","year":"2008","journal-title":"J. Neurochem."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1517\/14740330902859956","article-title":"Statins and the risk of Parkinson disease: an update on the controversy","volume":"8","author":"Becker","year":"2009","journal-title":"Expert Opin. Drug Saf."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12974-022-02584-x","article-title":"Neuroinflammation represents a common theme amongst genetic and environmental risk factors for alzheimer and Parkinson diseases","volume":"19","author":"Boyd","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/Jpd-150642","article-title":"The synaptic function of \u03b1-synuclein","volume":"5","author":"Burr\u00e9","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e70280","DOI":"10.1002\/prp2.70280","article-title":"The use of statins in Parkinson\u2019s and alzheimer\u2019s disease: a 2021-2025 state-of-the-art review of clinical and preclinical evidence","volume":"14","author":"Chiatto","year":"2026","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e0043123","DOI":"10.1128\/msphere.00431-23","article-title":"Gut microbiota-associated taurine metabolism dysregulation in a mouse model of Parkinson\u2019s disease","volume":"8","author":"Cui","year":"2023","journal-title":"mSphere"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e3002974","DOI":"10.1371\/journal.pbio.3002974","article-title":"The cholesterol 24-hydroxylase Cyp46A1 promotes \u03b1-synuclein pathology in Parkinson\u2019s disease","volume":"23","author":"Dai","year":"2025","journal-title":"PLoS Biol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/mds.29577","article-title":"27-hydroxycholesterol drives the spread of \u03b1-synuclein pathology in Parkinson\u2019s disease","volume":"38","author":"Dai","year":"2023","journal-title":"Movem. Dis."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/Circresaha.119.314929","article-title":"Lipids, apolipoproteins, and the risk of Parkinson disease","volume":"125","author":"Fang","year":"2019","journal-title":"Circ. Res."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.3390\/ijms19113667","article-title":"Methyl-\u03b2-cyclodextrin impairs the phosphorylation of the \u03b2\u2082 subunit of L-type calcium channels and cytosolic calcium homeostasis in mature cerebellar granule neurons","volume":"19","author":"Fortalezas","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1093\/brain\/awac176","article-title":"Lipid pathway dysfunction is prevalent in patients with Parkinson\u2019s disease","volume":"145","author":"Galper","year":"2022","journal-title":"Brain"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/mds.28396","article-title":"The role of cholesterol in \u03b1-synuclein and lewy body pathology in Gba1 Parkinson\u2019s disease","volume":"36","author":"Garc\u00eda-Sanz","year":"2021","journal-title":"Mov. Disord."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1093\/hmg\/ddaa085","article-title":"Glucocerebrosidase deficiency promotes release of \u03b1-synuclein fibrils from cultured neurons","volume":"29","author":"Gegg","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s13760-024-02709-4","article-title":"Statins as potential disease-modifying therapy of Parkinson\u2019s disease: a systematic review and meta-analysis with trial sequential analysis","volume":"125","author":"Gon\u00e7alves","year":"2025","journal-title":"Acta Neurol. Belg."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3233\/Jpd-130196","article-title":"Role of serum cholesterol in Parkinson\u2019s disease: a meta-analysis of evidence","volume":"3","author":"Gudala","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3109\/00207454.2014.979288","article-title":"The serum lipid profile of Parkinson\u2019s disease patients: a study from China","volume":"125","author":"Guo","year":"2015","journal-title":"Int. J. Neurosci."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.ajcnut.2025.07.018","article-title":"Investigating the impact of body weight changes and blood lipids on risk for mild cognitive impairment in Parkinson\u2019s disease: a prospective cohort study","volume":"122","author":"H\u00e5glin","year":"2025","journal-title":"Am. J. Clin. Nutr."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/joim.13541","article-title":"Deep brain stimulation for Parkinson\u2019s disease","volume":"292","author":"Hariz","year":"2022","journal-title":"J. Intern. Med."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"9773038","DOI":"10.1155\/2022\/9773038","article-title":"Lower blood lipid level is associated with the occurrence of Parkinson\u2019s disease: a meta-analysis and systematic review","volume":"2022","author":"Hong","year":"2022","journal-title":"Int. J. Clin. Pract."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1212\/01.wnl.0000312511.62699.a8","article-title":"Total cholesterol and the risk of Parkinson disease","volume":"70","author":"Hu","year":"2008","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/mds.22013","article-title":"Low LDL cholesterol and increased risk of Parkinson\u2019s disease: prospective results from Honolulu-Asia aging study","volume":"23","author":"Huang","year":"2008","journal-title":"Mov. Disord."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e22854","DOI":"10.1371\/journal.pone.0022854","article-title":"Serum cholesterol and the progression of Parkinson\u2019s disease: results from Datatop","volume":"6","author":"Huang","year":"2011","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1113\/jphysiol.2014.288209","article-title":"Cholesterol modulates open probability and desensitization of Nmda receptors","volume":"593","author":"Korinek","year":"2015","journal-title":"J. Physiol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e14411","DOI":"10.1111\/cns.14411","article-title":"The potential role of glucose metabolism, lipid metabolism, and amino acid metabolism in the treatment of Parkinson\u2019s disease","volume":"30","author":"Li","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"103787","DOI":"10.1016\/j.redox.2025.103787","article-title":"Decoding Parkinson\u2019s disease: the interplay of cell death pathways, oxidative stress, and therapeutic innovations","volume":"85","author":"Liu","year":"2025","journal-title":"Redox Biol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"107444","DOI":"10.1016\/j.psyneuen.2025.107444","article-title":"Association and biological pathways between metabolic syndrome and incident Parkinson\u2019s disease: a prospective cohort study of 289,150 participants","volume":"177","author":"Liu","year":"2025","journal-title":"Psychoneuroendocrinology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jns.2010.03.002","article-title":"Case-control study of risk of Parkinson\u2019s disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan","volume":"293","author":"Miyake","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson\u2019s disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1212\/01.wnl.0000271883.45010.8a","article-title":"Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease","volume":"69","author":"Simon","year":"2007","journal-title":"Neurology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1097\/Hep.0000000000000649","article-title":"Mendelian randomization in hepatology: a review of principles, opportunities, and challenges","volume":"81","author":"Song","year":"2025","journal-title":"Hepatology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41419-025-07333-5","article-title":"Infiltrating peripheral monocyte Trem-1 mediates dopaminergic neuron injury in substantia nigra of Parkinson\u2019s disease model mice","volume":"16","author":"Song","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1001\/jamaneurol.2022.3718","article-title":"Evaluation of simvastatin as a disease-modifying treatment for patients with Parkinson disease: a randomized clinical trial","volume":"79","author":"Stevens","year":"2022","journal-title":"JAMA Neurol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"106505","DOI":"10.1016\/j.nbd.2024.106505","article-title":"Targeting dysregulated lipid metabolism for the treatment of alzheimer\u2019s disease and Parkinson\u2019s disease: current advancements and future prospects","volume":"196","author":"Tong","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1212\/01.wnl.0000286942.14552.51","article-title":"Statin use and the risk of Parkinson disease","volume":"70","author":"Wahner","year":"2008","journal-title":"Neurology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3390\/jpm12050825","article-title":"Association between statin use and risk of Parkinson\u2019s disease: evidence from 18 observational studies comprising 3.7 million individuals","volume":"12","author":"Wu","year":"2022","journal-title":"J. Pers. Med."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/cns.12053","article-title":"Simvastatin induces neuroprotection in 6-Ohda-lesioned Pc12 via the Pi3K\/Akt\/caspase 3 pathway and anti-inflammatory responses","volume":"19","author":"Xu","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ophtha.2024.12.005","article-title":"Omega-3 fatty acids as protective factors for age-related macular degeneration: prospective cohort and mendelian randomization analyses","volume":"132","author":"Xue","year":"2025","journal-title":"Ophthalmology"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e214033","DOI":"10.1212\/Wnl.0000000000214033","article-title":"Metabolic syndrome and incidence of Parkinson disease: a community-based longitudinal study and meta-analysis","volume":"105","author":"Zhang","year":"2025","journal-title":"Neurology"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1841547\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:56:41Z","timestamp":1784699801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1841547\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":39,"alternative-id":["10.3389\/fnagi.2026.1841547"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1841547","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1841547"}}